Third Harmonic Bio
Rebecca Anne Young, MPH, is a seasoned professional in clinical operations with extensive experience across various organizations in the biotechnology and pharmaceutical sectors. Currently serving as the Director of Clinical Operations at Third Harmonic Bio, prior roles include Director of Clinical Operations at Hemab Therapeutics and Associate Director/Principal Scientist at Merck, where program-level oversight of multiple Phase III studies was a key responsibility. Rebecca has led significant global clinical trials, demonstrating expertise in managing diverse teams, developing and executing study protocols, and ensuring compliance with regulatory standards. Educational qualifications include a Master of Public Health from Boston University and a Bachelor of Science in Psychology and History from the University of Utah.
This person is not in any teams
Third Harmonic Bio
1 followers
Third Harmonic Bio is a clinical-stage company developing a first-in-class, highly selective, oral KIT inhibitor.